The Cure Starts Now has funded $18,068,037 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 114 grants at over 100 hospitals in 15 countries.


CONNECT Consortium - $1,859,978.26

Amount
$1,859,978.00
Date
September 2020

CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium

International DIPG/DMG Registry And Repository - $862,671

Amount
$862,671.00
Date
May 2020

Funding of Pediatric Brain Tumor Consortium Foundation - $25,000

Amount
$25,000.00
Date
January 2020

Sydney Children's Hospital - $151,468

Amount
$151,468.00
Date
December 2019

Developing New Epigenetic Combination Treatments Against DIPG.

Oncoceutics ONC201 - $100,000

Amount
$100,000.00
Date
December 2019

Expansion of the ONC201 Compassionate Use.

University of Sydney - $100,000

Amount
$100,000.00
Date
November 2019

Targeting hypoxia and mitochondrial metabolism with repurposing drugs as an approach of radiosensitization for diffuse intrinsic pontine gliomas.

University of Michigan Hospitals - $157,856

Amount
$157,856.00
Date
November 2019

Therapeutic reversal of pre-natal pontine ID1 signaling in DIPG

Dayton Children's Hospital - $69,600

Amount
$69,600.00
Date
November 2019

Responses of distinct cell populations to PDGFRA inhibitors in diffuse intrinsic pontine glioma.